C/EBPβ–VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD
Background & Aims: Kupffer cells (KCs) can promote hepatic inflammation in metabolic dysfunction-associated steatotic liver disease (MASLD), but the underlying molecular mechanisms are not fully understood. C/EBPβ in macrophages can mediate metabolic and immune dysregulations. Therefore, we...
Saved in:
| Main Authors: | Shuang-Zhe Lin, Yang Xie, Yu-Qing Cheng, Rui Xue, Yin-Shi Su, Mingxi Liu, Yuan-Wen Chen, Jian-Gao Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | JHEP Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555925000953 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom
by: Elizabeta Knezović, et al.
Published: (2025-02-01) -
β-Resorcylic acid prevents MASLD in ob/ob mice by modulating lipid metabolism and inflammation in the liver
by: Sergio López-Herrador, et al.
Published: (2025-09-01) -
Microglial C/EBPβ-Fcgr1 regulatory axis blocking inhibits microglial pyroptosis and improves neurological recovery
by: Jing Li, et al.
Published: (2025-01-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
by: Ankita Dua, et al.
Published: (2025-08-01) -
Suppression of Hepatocellular Carcinoma by Deletion of SIRT2 in Hepatocytes via Elevated C/EBPβ/GADD45γSummary
by: Fang Wang, et al.
Published: (2025-01-01)